Title: Jennifer PITZEN , et al. C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors. WO2019212990A1.
1239588-11-4
1245823-50-0
1286281-32-0
13937-08-1
1446282-18-3
149577-05-9
185022-12-2 | Aminooxy-peg2-alcohol | AA019E4G | MFCD30182047
2086689-05-4 | 2-(Azido-PEG3-amido)-1,3-bis(carboxylethoxy)propane | AA019E8S | MFCD30723261
1539292-59-5 | tert-butyl 3-(4-(3-hydroxyprop-1-ynyl)phenylcarbamoyl)propylcarbamate | AA019EDQ | MFCD31561134
2183440-72-2 | N-(Azido-PEG3)-NH-PEG3-acid HCl salt | AA019EH2 | MFCD31692222
56393-56-7 | N-(2,5-dimethoxyphenyl)-4-methylbenzenesulfonamide | AA019EKF | MFCD00686787
1451392-80-5 | tert-Butyl 4a,7-dihydro-1H-dicyclopenta[b,c]azete-4(3aH)-carboxylate | AA019ENJ | MFCD23704693
1067186-56-4 | 2-(1-(4-Chlorophenyl)cyclopropyl)-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid | AA019EQO | MFCD18782752
116-41-6 | N-(2-methoxy-5-methylphenyl)-4-methylbenzenesulfonamide | AA019ETH | MFCD05170076
1391733-05-3 | 1-(Tetrahydrofuran-3-yl)piperazine hydrochloride | AA019EWS | MFCD19441814
13589-02-1 | H-Pro-Phe-OH | AA019FP2 | MFCD00037869